COMMUNIQUÉS West-GlobeNewswire
-
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
11/06/2024 - 14:40 -
NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
11/06/2024 - 14:44 -
International Myeloma Foundation (IMF) to Honor 2024 Kyle and Durie Achievement Awardees, Dr. Shaji Kumar and Dr. Francesca Gay
11/06/2024 - 14:45 -
IntelGenx Announces Initiation of the Sale and Investment Solicitation Process
11/06/2024 - 14:52 -
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
11/06/2024 - 15:00 -
Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease
11/06/2024 - 15:00 -
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
11/06/2024 - 15:00 -
Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
11/06/2024 - 15:00 -
Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®
11/06/2024 - 15:00 -
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
11/06/2024 - 15:00 -
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
11/06/2024 - 15:05 -
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
11/06/2024 - 15:25 -
Racial Disparities in HIV Testing Require Explanation, according to Journal of American Physicians and Surgeons
11/06/2024 - 16:10 -
AI Brain Health Leader Omniscient Closes Series C Funding Round
11/06/2024 - 17:00 -
Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National Capital
11/06/2024 - 17:02 -
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
11/06/2024 - 17:11 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2024
11/06/2024 - 18:00 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2024
11/06/2024 - 18:00 -
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
11/06/2024 - 18:15
Pages